MYCN and cancer: Deregulated expression of the MYC family of oncogenes/transcription factors MYC, MYCN, and MYCL (here collectively referred to as “MYC”) occurs in more than half of all cancers, and is often strongly associated with aggressive tumors, resistance to therapy, and poor prognosis (1, 2).